: CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.
The deubiquitinase activity of CYLD is required for B cell differentiation / Pseftogas, Athanasios; Bordini, Jessica; Gavriilidis, George; Frenquelli, Michela; Campanella, Alessandro; Rovida, Alessandra; Morello, Gaia; Gerousi, Marina; Theodosiou, Eleni; Fragkouli, Styliani-Christina; Vasileiou, Vasileios; Sklaviadis, Theodoros; Dafou, Dimitra; Mosialos, George; Tripodo, Claudio; Psomopoulos, Fotis; Winkler, Thomas H; Stamatopoulos, Kostas; Ghia, Paolo; Xanthopoulos, Konstantinos. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - (2026). [10.1038/s41419-026-08555-x]
The deubiquitinase activity of CYLD is required for B cell differentiation
Bordini, Jessica;Campanella, Alessandro;Rovida, Alessandra;
2026-01-01
Abstract
: CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


